{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:33:30Z","timestamp":1708648410871},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00108-024-01666-7","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T17:02:59Z","timestamp":1708016579000},"page":"229-238","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pr\u00e4zisionsmedizin in der Diagnostik und Therapie von Asthma","Precision medicine in the diagnosis and treatment of asthma"],"prefix":"10.1007","volume":"65","author":[{"given":"Marek","family":"Lommatzsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,15]]},"reference":[{"issue":"9","key":"1666_CR1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1056\/NEJMra1102783","volume":"366","author":"E von Mutius","year":"2012","unstructured":"von Mutius\u00a0E, Drazen\u00a0JM (2012) A\u00a0patient with asthma seeks medical advice in 1828, 1928, and 2012. N\u00a0Engl J Med 366(9):827\u2013834","journal-title":"N Engl J Med"},{"issue":"10335","key":"1666_CR2","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/S0140-6736(22)00331-2","volume":"399","author":"M Lommatzsch","year":"2022","unstructured":"Lommatzsch\u00a0M, Brusselle\u00a0GG, Canonica\u00a0GW et\u00a0al (2022) Disease-modifying anti-asthmatic drugs. Lancet 399(10335):1664\u20131668","journal-title":"Lancet"},{"issue":"7","key":"1666_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s15006-022-0992-y","volume":"164","author":"M Lommatzsch","year":"2022","unstructured":"Lommatzsch\u00a0M (2022) Symptom prevention: the new era of asthma treatment. MMW Fortschr Med 164(7):50\u201351","journal-title":"MMW Fortschr Med"},{"key":"1666_CR4","doi-asserted-by":"crossref","unstructured":"Bruce P, Hatter L, Houghton C et\u00a0al (2023) The Anti-Inflammatory Reliever (AIR) algorithm study: a\u00a0protocol for a\u00a0single-group study of an AIR stepwise approach to the treatment of adult asthma. ERJ Open Res 9(5)","DOI":"10.1183\/23120541.00239-2023"},{"issue":"2","key":"1666_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10405-022-00433-5","volume":"19","author":"M Lommatzsch","year":"2022","unstructured":"Lommatzsch\u00a0M (2022) Diagnostik und Therapie von Asthma bei Erwachsenen. Der Pneumologe 19(2):111\u2013121","journal-title":"Der Pneumologe"},{"issue":"4","key":"1666_CR6","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1001\/archinte.1918.00090150111007","volume":"12","author":"FM Rackemann","year":"1918","unstructured":"Rackemann\u00a0FM (1918) A\u00a0clinical study of one hundred and fifty cases of bronchial asthma. Arch Intern Med 12(4):517\u2013552","journal-title":"Arch Intern Med"},{"issue":"8","key":"1666_CR7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1055\/a-2070-2135","volume":"77","author":"M Lommatzsch","year":"2023","unstructured":"Lommatzsch\u00a0M, Cri\u00e9e\u00a0CP, de Jong\u00a0CCM et\u00a0al (2023) Diagnosis and treatment of asthma: a\u00a0guideline for respiratory specialists 2023\u2014published by the German Respiratory Society (DGP) e.\u202fV. Pneumologie 77(8):461\u2013543","journal-title":"Pneumologie"},{"key":"1666_CR8","unstructured":"Global Initiative for Asthma (GINA). www.ginasthma.com"},{"issue":"6","key":"1666_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S2213-2600(22)00490-8","volume":"11","author":"M Lommatzsch","year":"2023","unstructured":"Lommatzsch\u00a0M, Brusselle\u00a0GG, Levy\u00a0ML et\u00a0al (2023) A2BCD: a\u00a0concise guide for asthma management. Lancet Respir Med 11(6):573\u2013576","journal-title":"Lancet Respir Med"},{"issue":"12","key":"1666_CR10","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1159\/000534922","volume":"102","author":"M Lommatzsch","year":"2023","unstructured":"Lommatzsch\u00a0M, Mohme\u00a0SN, Stoll\u00a0P, Virchow\u00a0JC (2023) Response to various biologics in patients with both asthma and chronic obstructive pulmonary disease. Respiration 102(12):986\u2013990","journal-title":"Respiration"},{"key":"1666_CR11","doi-asserted-by":"crossref","unstructured":"Kraft M, Brusselle G, FitzGerald JM et\u00a0al (2021) Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma. Eur Respir\u00a0J 58(6)","DOI":"10.1183\/13993003.00413-2021"},{"issue":"2","key":"1666_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/thoraxjnl-2021-217325","volume":"77","author":"S Couillard","year":"2022","unstructured":"Couillard\u00a0S, Laugerud\u00a0A, Jabeen\u00a0M et\u00a0al (2022) Derivation of a\u00a0prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide. Thorax 77(2):199\u2013202","journal-title":"Thorax"},{"issue":"3","key":"1666_CR13","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/ard.2011.149765","volume":"70","author":"DT Felson","year":"2011","unstructured":"Felson\u00a0DT, Smolen\u00a0JS, Wells\u00a0G et\u00a0al (2011) American college of rheumatology\/european league against rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis 70(3):404\u2013413","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1666_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1136\/ard-2022-223365","volume":"82","author":"A Kerschbaumer","year":"2023","unstructured":"Kerschbaumer\u00a0A, Sepriano\u00a0A, Bergstra\u00a0SA et\u00a0al (2023) Efficacy of synthetic and biological DMARDs: a\u00a0systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 82(1):95\u2013106","journal-title":"Ann Rheum Dis"},{"issue":"14","key":"1666_CR15","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1056\/NEJMoa2303452","volume":"389","author":"RF Spiera","year":"2023","unstructured":"Spiera\u00a0RF, Unizony\u00a0S, Warrington\u00a0KJ et\u00a0al (2023) Sarilumab for relapse of polymyalgia rheumatica during glucocorticoid taper. N\u00a0Engl J Med 389(14):1263\u20131272","journal-title":"N Engl J Med"},{"issue":"3","key":"1666_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41584-021-00739-3","volume":"18","author":"AR Parra S\u00e1nchez","year":"2022","unstructured":"Parra S\u00e1nchez\u00a0AR, Voskuyl\u00a0AE, van Vollenhoven\u00a0RF (2022) Treat-to-target in systemic lupus erythematosus: advancing towards its implementation. Nat Rev Rheumatol 18(3):146\u2013157","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"1666_CR17","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","volume":"160","author":"D Turner","year":"2021","unstructured":"Turner\u00a0D, Ricciuto\u00a0A, Lewis\u00a0A et\u00a0al (2021) STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology 160(5):1570\u20131583","journal-title":"Gastroenterology"},{"issue":"8","key":"1666_CR18","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/art.41773","volume":"73","author":"SA Chung","year":"2021","unstructured":"Chung\u00a0SA, Langford\u00a0CA, Maz\u00a0M et\u00a0al (2021) 2021 American College of Rheumatology\/vasculitis foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol 73(8):1366\u20131383","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"1666_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1530\/EJE-21-0077","volume":"185","author":"JM van Lieshout","year":"2021","unstructured":"van Lieshout\u00a0JM, Mooij\u00a0CF, van Trotsenburg\u00a0ASP, Zwaveling-Soonawala\u00a0N (2021) Methimazole-induced remission rates in pediatric Graves\u2019 disease: a\u00a0systematic review. Eur J Endocrinol 185(2):219\u2013229","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1666_CR20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S2213-2600(23)00415-0","volume":"12","author":"M Lommatzsch","year":"2024","unstructured":"Lommatzsch\u00a0M, Buhl\u00a0R, Canonica\u00a0GW, Ribas\u00a0CD, Nagase\u00a0H, Brusselle\u00a0GG, Jackson\u00a0DJ, Pavord\u00a0ID, Korn\u00a0S, Milger\u00a0K, Taube\u00a0C, Virchow\u00a0JC (2024) Pioneering a paradigm shift in asthma management: remission as a treatment goal. Lancet Respir Med 12(2):96\u201399","journal-title":"Lancet Respir Med"},{"issue":"8","key":"1666_CR21","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1159\/000524712","volume":"101","author":"M Wollsching-Strobel","year":"2022","unstructured":"Wollsching-Strobel\u00a0M, Butt\u00a0U, Majorski\u00a0DS et\u00a0al (2022) Evolution of web-based training videos provided by the German Respiratory League for the correct inhalation technique. Respiration 101(8):757\u2013765","journal-title":"Respiration"},{"key":"1666_CR22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.rmed.2017.06.009","volume":"129","author":"T Muller","year":"2017","unstructured":"Muller\u00a0T, Muller\u00a0A, Hubel\u00a0C et\u00a0al (2017) Optimizing inhalation technique using web-based videos in obstructive lung diseases. Respir Med 129:140\u2013144","journal-title":"Respir Med"},{"key":"1666_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.5414\/ALX02331E","volume":"6","author":"O Pfaar","year":"2022","unstructured":"Pfaar\u00a0O, Ankermann\u00a0T, Augustin\u00a0M et\u00a0al (2022) Guideline on allergen immunotherapy in IgE-mediated allergic diseases. Allergol Sel 6:167\u2013232","journal-title":"Allergol Sel"},{"issue":"16","key":"1666_CR24","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1001\/jama.2016.3964","volume":"315","author":"J Virchow","year":"2016","unstructured":"Virchow\u00a0J, Backer\u00a0V, Kuna\u00a0P et\u00a0al (2016) Efficacy of a\u00a0house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a\u00a0randomized clinical trial. JAMA 315(16):1715\u20131725","journal-title":"JAMA"},{"key":"1666_CR25","doi-asserted-by":"crossref","unstructured":"Nwaru BI, Ekstr\u00f6m M, Hasvold P, Wiklund F, Telg G, Janson C (2020) Overuse of short-acting \u03b2(2)-agonists in asthma is associated with increased risk of exacerbation and mortality: a\u00a0nationwide cohort study of the global SABINA programme. Eur Respir\u00a0J 55(4)","DOI":"10.1183\/13993003.01872-2019"},{"issue":"1","key":"1666_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S2213-2600(20)30389-1","volume":"9","author":"LA Lee","year":"2021","unstructured":"Lee\u00a0LA, Bailes\u00a0Z, Barnes\u00a0N et\u00a0al (2021) Efficacy and safety of once-daily single-inhaler triple therapy (FF\/UMEC\/VI) versus FF\/VI in patients with inadequately controlled asthma (CAPTAIN): a\u00a0double-blind, randomised, phase 3A trial. Lancet Respir Med 9(1):69\u201384","journal-title":"Lancet Respir Med"},{"issue":"9","key":"1666_CR27","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1016\/j.jaip.2023.05.047","volume":"11","author":"K Milger","year":"2023","unstructured":"Milger\u00a0K, Suhling\u00a0H, Skowasch\u00a0D et\u00a0al (2023) Response to biologics and clinical remission in the adult German asthma net severe asthma registry cohort. J\u00a0Allergy Clin Immunol Pract 11(9):2701\u20132712.e2","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10423","key":"1666_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0140-6736(23)02284-5","volume":"403","author":"DJ Jackson","year":"2024","unstructured":"Jackson\u00a0DJ, Heaney\u00a0LG, Humbert\u00a0M, Kent\u00a0BD, Shavit\u00a0A, Hiljemark\u00a0L, Olinger\u00a0L, Cohen\u00a0D, Menzies-Gow\u00a0A, Korn\u00a0S; SHAMAL Investigators (2024) Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study. Lancet 403(10423):271\u2013281","journal-title":"Lancet"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-024-01666-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-024-01666-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-024-01666-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T12:19:33Z","timestamp":1708604373000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-024-01666-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["1666"],"URL":"https:\/\/doi.org\/10.1007\/s00108-024-01666-7","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,15]]},"assertion":[{"value":"8 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Lommatzsch: Forschungsunterst\u00fctzung von: DFG, GSK, AstraZeneca. Honorare f\u00fcr Vortrags- und Beratert\u00e4tigkeiten von: ALK, Allergopharma, AstraZeneca, Bencard, Berlin-Chemie, Boehringer Ingelheim, Bosch, Chiesi, Circassia, GSK, HAL Allergy, Janssen-Cilag, Leti, MSD, Mundipharma, Novartis, Nycomed\/Takeda, Sanofi, Stallergenes, TEVA, UCB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}